CapsoVision, Inc

CapsoVision, Inc. announced the appointment of Dr. David S. Shields, a board-certified gastroenterologist with over 40 years of experience, to its Board of Directors, effective July 1, 2026. Dr. Shields has been a clinical advisor to the company for nearly a decade. He succeeds Dr. Joanne C. Imperial, who stepped down from the Board but will continue to support the company as an independent clinical consultant. This appointment comes as CapsoVision approaches key milestones, including the commercial launch of its AI-assisted reading feature for CapsoCam Plus® and the advancement of its CapsoCam Colon™ program.

CapsoVision reported a net loss of $7.03 million for the first quarter of 2026, an increase from $5.38 million in the prior year, while net revenue remained relatively flat at $2.79 million. The company successfully raised approximately $14 million in gross proceeds through a private placement of common stock in March 2026. Despite this capital infusion, management expressed substantial doubt about the company's ability to continue as a going concern for the next year, citing ongoing operating losses and negative cash flows.

CapsoVision reported stable first-quarter 2026 revenue of $2.8 million, consistent with the prior year, but experienced an increased net loss of $(7.0) million. The company secured key customer renewals and saw growing adoption of CapsoCam Plus®. Significant pipeline progress includes anticipated mid-year FDA clearance for its AI-assisted reading feature and initiation of a clinical study for CapsoCam UGI. Additionally, CapsoVision completed a $14 million private placement financing.

CapsoVision, Inc. announced it will release its first quarter 2026 financial results on Thursday, May 14, 2026, after market close. The company will host a conference call and live webcast on the same day at 1:30 pm PT / 4:30 pm ET to discuss the results and provide a corporate update. Investors can access the call via phone or webcast on the company's investor relations website.

CapsoVision, Inc. will hold its 2026 Annual Meeting of Stockholders virtually on June 11, 2026, at 9:00 a.m. Pacific Daylight Time. Stockholders will vote on the re-election of three Class I directors and the ratification of Baker Tilly US, LLP as the independent registered public accounting firm for 2026. The Board recommends voting for all nominees and the auditor's appointment.